Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
18,126
Total Claims
$1.9M
Drug Cost
760
Beneficiaries
$2,439
Cost/Patient
Risk Score Breakdown 3/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
-97%
Opioid rate vs peers
0.1% vs 2.2% avg
+73%
Cost per patient vs peers
$2,439 vs $1,411 avg
+18%
Brand preference vs peers
12.5% vs 10.6% avg
Opioid Prescribing
0.1%
Opioid Rate
11
Opioid Claims
$57
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 2,257 claims · $1.3M
Generic: 15,755 claims · $536K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Empagliflozin | 405 | $394K |
| Sitagliptin Phosphate | 181 | $172K |
| Icosapent Ethyl | 301 | $159K |
| Icosapent Ethyl | 219 | $111K |
| Lipase/Protease/Amylase | 89 | $108K |
| Semaglutide | 55 | $67K |
| Dapagliflozin Propanediol | 56 | $51K |
| Diclofenac Sodium | 500 | $35K |
| Budesonide/Formoterol Fumarate | 77 | $33K |
| Insulin Glargine,hum.Rec.Anlog | 65 | $32K |
| Rivaroxaban | 35 | $32K |
| Linagliptin | 28 | $31K |
| Atorvastatin Calcium | 1,281 | $28K |
| Apixaban | 24 | $26K |
| Omega-3 Acid Ethyl Esters | 309 | $25K |
Prescribing Profile
Patient Profile
76
Avg Age
53%
Female
1.12
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data